VENICE, Italy — New data suggests that the reason type 2 diabetes is more common in obese men than in women may be due to differences...
Amid growing concerns about the potential long-term costs of using glucagon-like peptide 1 (GLP-1) agonists to treat obesity, some insurance companies are facilitating access to bariatric...
Tirzepatide (Zepbound for weight loss, Mounjaro, Eli Lilly for type 2 diabetes) consistently reduces body weight regardless of pretreatment body mass index (BMI) and reduces body...
Recent Comments